Inhibition of microRNA-660-5p decreases breast cancer progression through direct targeting of TMEM41B
Abstract Background Breast cancer is the most prevalent cancer among women worldwide. Most breast cancer-related deaths result from metastasis and drug resistance. Novel therapies are imperative for targeting metastatic and drug-resistant breast cancer cells. Accumulating evidence suggests that dysr...
Saved in:
| Main Authors: | Valeria Villarreal-García, José Roberto Estupiñan-Jiménez, Vianey Gonzalez-Villasana, Pablo E. Vivas-Mejía, Marienid Flores-Colón, Irma Estefanía Ancira-Moreno, Patricio Adrián Zapata-Morín, Claudia Altamirano-Torres, José Manuel Vázquez-Guillen, Cristina Rodríguez-Padilla, Recep Bayraktar, Mohamed H. Rashed, Cristina Ivan, Gabriel Lopez-Berestein, Diana Reséndez-Pérez |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2024-12-01
|
| Series: | Hereditas |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s41065-024-00357-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges and innovations in primary sclerosing cholangitis clinical trials: Evaluating HK-660S and the path forward: Editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
by: Nilanga Nishad
Published: (2025-04-01) -
Healthy Living for Elders: Tips for Remembering Your Medication
by: Linda B. Bobroff
Published: (2004-07-01) -
A novel clinical trial for primary sclerosing cholangitis from Asia: All regional endeavors should improve global management of primary sclerosing cholangitis: Editorial on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
by: Atsumasa Komori
Published: (2025-04-01) -
Genomic Analysis and Virulence Assessment of Hypervirulent Klebsiella pneumoniae K16-ST660 in Severe Cervical Necrotizing Fasciitis
by: Jun Huang, et al.
Published: (2024-12-01) -
MicroRNA‐1307‐3p contributes to breast cancer progression through PRM2
by: José Roberto Estupiñan‐Jiménez, et al.
Published: (2024-11-01)